The Gilles de la Tourette syndrome: an update

Psychiatry

Volumn 3, Issue 8, 2004, Pages 3-7

  Robertson, Mary M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

aetiology; attention deficit hyperactivity disorder (ADHD); management; obsessive compulsive behaviours (OCB); phenomenology; prevalence; Tourette syndrome; treatment; unusual psychiatric syndromes

Indexed keywords

EID: 77950202359     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1383/psyt.3.8.3.43393     Document Type: Article

References (33)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition (2000), American Psychiatric Association, Washington, DC text revised (DSM-IV-TR)
2. Baron-Cohen S., Scahill V.L., Izaguirre J., Hornsey H., and Robertsn M.M. The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism: a large scale study. Psychol Med 29 (1999) 1151-1159
3. Berthier M.L., Kulisevsky J., and Campos V.M. Bipolar disorder in adult patients with Tourette's syndrome: a clinical study. Biol Psychiatry 43 (1998) 364-370
4. Budman C.L., Gayer A., Lesser M.N., Shi Q., and Bruun R.D. An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. J Clin Psychiatry 62 (2001) 290-294
5. Carroll A., and Robertson M.M. Tourette Syndrome: A Practical Guide for Teachers, Parents and Carers (2000), David Fulton, London
6. Church A.J., Dale R.C., Lees A.J., Giovannoni G., and Robertson M.M. Tourette's syndrome: a cross-sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 74 (2003) 602-607
7. Curtis D., Brett P., Dearlove A.M., et al. Genome scan of Tourette syndrome in a single large pedigree shows some support for linkage to regions of chromosomes 5, 10 and 13. Psychiatr Genet 14 (2004) 83-87
8. Diaz-Anzaldua A., Joober R., Riviere J.B., et al. Montreal Tourette Syndrome Study Group. Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population. Mol Psychiatry 9 (2004) 272-277
9. Eapen V., Lees A.J., Lakke J.P.W.F., Trimble M.R., and Robertson M.M. Adult-onset tic disorders. Mov Disord 17 (2002) 735-740
10. Elstner K., Selai C.E., Trimble M.R., and Robertson M.M. Quality of Life (QOL) of patients with Gilles de la Tourette's syndrome. Acta Psychiatr Scand 103 (2001) 52-59
11. Freeman R.D., Fast D.K., Burd L., et al. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 42 (2000) 436-447
12. Jankovic J. Tourette's syndrome. N Engl J Med 345 (2001) 1184-1192
13. Kunwar A.R., and Megna J.L. Resolution of risperidone-induced hyperprolactinaemia with substitution of quetiapine. Ann Pharmacother 37 (2003) 206-208
14. Kurlan R., McDermott M.P., Deeley C., et al. Prevalence of tics in schoolchildren and association with placement in special education. Neurology 57 (2001) 1383-1388
15. Leckman J.F., Dolansky E.S., Hardin M.T., et al. Perinatal factors in the expression of Tourette's syndrome: an exploratory study. J Am Acad Child Adolesc Psychiatry 29 (1990) 220-226
16. Leckman J.F., Zhang H., Vitale A., et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 102 (1998) 14-19
17. Merette C., Brassard A., Potvin A., et al. Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet 67 (2000) 1008-1013
18. National Statistics Office and Information Service. Room 1.015, Cardiff Road, Newport NP10 8XG, 2002.
19. Parraga H.C., Parraga M.I., Woodward R.L., and Fenning P.A. Quetiapine treatment of children with Tourette's syndrome: report of two cases. J Child Adolesc Psychopharmacol 11 (2001) 187-191
20. Perugi G., Toni C., Frare F., et al. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry 63 (2002) 1129-1134
21. Piacentini J., and Chang S. Behavioral treatments for Tourette syndrome and tic disorders: state of the art. Adv Neurol 85 (2001) 319-331
22. Rickards H., and Robertson M.M. A controlled study of psychopathology and associated symptoms in Tourette syndrome. World J Biol Psychiatry 4 (2003) 64-68
23. Robertson M.M. Tourette syndrome, associated conditions and the complexities of treatment. Brain 123 (2000) 425-462
24. Robertson M.M. Tourette syndrome. PSYCHIATRY 1 7 (2002) 78-82
25. Robertson M.M. The heterogeneous psychopathology of Tourette syndrome. In: Bedard M.A., Agid Y., Chouinard S., Fahn S., Korczyn A.D., and Lesperance P. (Eds). Mental and Behavioural Dysfunction in Movement Disorders (2003), Humana Press, Totowa, NJ
26. Scahill L., Leckman J.F., Schultz R.T., Katsovich L., and Peterson B.S. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 60 (2003) 1130-1135
27. Simonic I., Gericke G.S., Ott J., and Weber J.L. Identification of genetic markers associated with Gilles de la Tourette syndrome in an Afrikaner population. Am J Med Genet 63 (1998) 839-846
28. Simonic I., Nyholt D.R., Gericke G.S., et al. Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosomes 2p11, 8q22 and 11q23-24 in South African Afrikaners. Am J Med Genet 105 (2001) 163-167
29. Swedo S.E., Leonard H.L., Garvey M., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155 (1998) 264-271
30. The Tourette Syndrome Association International Consortium for Genetics. A complete genome scan in sib-pairs affected by Gilles de la Tourette Syndrome. Am J Hum Genet 65 (1999) 1428-1436
31. Wilens T.E., Biederman J., Wozniak J., et al. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biol Psychiatry 54 (2003) 1-8
32. Wilhelm S., Deckersbach T., Coffey B.J., et al. Habit reversal versus supportive therapy for Tourette's disorder: a randomised controlled trial. Am J Psychiatry 160 (2003) 1175-1177
33. World Health Organization. International Classification of Diseases and Health-Related Problems. 10th revision (ICD-10) (1992), World Health Organization, Geneva